http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102764250-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a42d396369b77b87cf885141edea56c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
| filingDate | 2011-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f72e4b928d18d503a01af8534f76c417 |
| publicationDate | 2014-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102764250-B |
| titleOfInvention | Composition composed of taurine and ginkgolide A and application thereof |
| abstract | A compound preparation for treating cardiovascular diseases in the invention is prepared from the following active components according to the following weight ratio with the assistance of routine pharmaceutic adjuvants through a routine technology: 100mg-400mg of taurine and 20-80mg of ginkgolide. The compound composition has a function of inhibiting platelet aggregation. By the use of the compound composition, rat myocardial infarction rate is reduced. |
| priorityDate | 2011-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.